Farmacja Polska
September 28, 2020
Agata Tadeja
1 citation
Research on using drugs in medicine was almost completely stopped and delegalized in 1971, by Convention on Psychotropic Substances. Most of studies carried out before 1971 were methodologically inappropriate according to current research methodologies, yet it was proven that there is some potential in using substances like lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine,...
Smart Biofeedback - Perspectives and Applications
September 28, 2020
Jeff Tarrant
11 citations
Beginning meditators often complain that they do not know if they are “doing it right” or give up before realizing significant benefits. Advanced meditators often reach a plateau and struggle to reach “the next level” of their practice. Modern researchers and practitioners are finding a possible new solution to these challenges by using EEG biofeedback to increase awareness of subtle states of...
Journal of Evidence-Based Integrative Medicine
September 25, 2020
Medha Kaushik, Akarshi Jain, Puneet Agarwal et al.
During recent decades, stress-related neuropsychiatric disorders such as anxiety, depression, chronic tension headache, and migraine have established their stronghold in the lives of a vast number of people worldwide. In order to address this global phenomenon, intensive studies have been carried out leading to the advancement of drugs like anti-depressants, anxiolytics, and analgesics which...
Mindfulness
September 24, 2020
S. Kriakous, K. Elliott, Carolien Lamers et al.
Burnout and occupational stress are frequently experienced by healthcare professionals (HCPs). Mindfulness-based stress reduction (MBSR) has been found to improve the psychological health outcomes of HCPs. To date, systematic reviews and meta-analyses have primarily focused upon empirical investigations into the reduction of stress amongst HCPs using MBSR and are limited to empirical studies...
EClinicalMedicine
September 24, 2020
B. Anderson, Alicia Danforth, Prof Robert Daroff et al.
271 citations
BACKGROUND: Psilocybin therapy has shown promise as a rapid-acting treatment for depression, anxiety, and demoralization in patients with serious medical illness (e.g., cancer) when paired with individual psychotherapy. This study assessed the safety and feasibility of psilocybin-assisted group therapy for demoralization in older long-term AIDS survivor (OLTAS) men, a population with a high...
Pharmacology, Biochemistry, and Behavior
September 22, 2020
Kennett D. Radford, Rina Y. Berman, Michael Zhang et al.
Ketamine, a multimodal dissociative anesthetic drug, is widely used to treat various conditions including acute pain and treatment-resistant depression. We previously reported that subanesthetic doses of intravenous (i.v.) ketamine produced transient dissociative stereotypy and antinociception in male rats. However, sex-related differences in the effects of i.v. ketamine on these measures are...
Trials
September 22, 2020
Gladys E Ibañez, Kristopher Fennie, Linda Larkey et al.
Background: Almost half of people living with HIV (PLWH) in the USA are over 50 years of age; this is expected to increase to 70% by 2020. Yet, few interventions exist for older PLWH that address psychological and physical symptoms combined, both prevalent in this population. There is a need to find innovative and accessible interventions that can help older PLWH to manage their symptoms....
A&A Practice
September 21, 2020
Isaiah T. Crum, VaKara M. Meyer Karre, Alëna A. Balasanova
A 76-year-old woman with chronic noncancer pain and an intrathecal hydromorphone–bupivacaine pump was admitted for acute exacerbation of heart failure. Her pump was unable to be replaced due to medical comorbidities. She was unable to tolerate oral opioids due to ventilatory depression. Tapering hydromorphone resulted in opioid withdrawal due to physiological dependence. Microdosing of...
Journal of Evolutionary Psychology
September 21, 2020
Monnica T. Williams, Sara Reed, Jamilah R. George
62 citations
Abstract Psychedelic medicine is an emerging field of research and practice that examines the psychotherapeutic effects of substances classified as hallucinogens on the human mind, body, and spirit. Current research explores the safety and efficacy of these substances for mental health disorders including anxiety, depression, and posttraumatic stress disorder (PTSD). Although current studies...
Journal of Psychoactive Drugs
September 15, 2020
Tracey Varker, Loretta Watson, Kari Gibson et al.
57 citations
The aim of this systematic review was to examine the efficacy of MDMA, ketamine, LSD, and psilocybin for the treatment of posttraumatic stress disorder (PTSD). A search of four databases for English language, peer-reviewed literature published from inception to 18th October 2019 yielded 2,959 records, 34 of which were screened on full-text. Observational studies and RCTs which tested the...